Understanding Varicose Veins: Key Information

Clinical Overview

Varicose veins, characterized by abnormally dilated, tortuous superficial veins resulting from progressive venous insufficiency and valve dysfunction, affect approximately 23% of adults and increase in prevalence with age, female sex, prolonged standing occupations, pregnancy, and genetic predisposition. Unlike fine spider veins amenable to sclerotherapy or laser treatment, varicose veins require more aggressive intervention reflecting deeper vein involvement and hemodynamic compromise. Understanding when to pursue medical versus purely cosmetic evaluation prevents inappropriate treatment delay in patients with underlying deep venous insufficiency. Symptomatic varicose veins (pain, swelling, skin changes, ulceration) warrant vascular medicine or surgery consultation assessing for complications and appropriate intervention. Asymptomatic cosmetic varicose veins may pursue office-based treatments (sclerotherapy, endovenous closure) versus surgical stripping depending on vein size and location.

How It Works

Varicose vein pathophysiology involves progressive valve incompetence within superficial veins (greater saphenous, lesser saphenous, branch tributaries) causing venous reflux and progressive vein dilation. Normally-functioning venous valves prevent retrograde blood flow; however, valve damage from various etiologies (genetic predisposition, trauma, thrombosis, chronic venous hypertension) enables blood pooling in dependent positions. Hydrostatic pressure from column of pooled blood chronically distends vein walls causing progressive collagen degradation, smooth muscle dysfunction, and permanent vein enlargement. Stasis within dilated vein lumen predisposes to thrombosis (clotting), inflammation, and local skin changes from chronic hypoxia and inflammation. Treatment approaches address underlying pathophysiology through distinct mechanisms: sclerotherapy chemically injures vein wall causing thrombosis and fibrosis; endovenous thermal ablation (radiofrequency, laser) applies heat destroying vein wall through thermal coagulation; mechanical techniques (phlebectomy) surgically remove veins; and compression restores normal venous hemodynamics preventing progression.

Ideal Candidates

Varicose vein treatment candidates present with dilated superficial veins (typically greater than 3mm diameter) causing cosmetic concern or symptoms (pain, swelling, skin changes). Ideal candidates undergo appropriate diagnostic evaluation (duplex ultrasound) assessing deep venous system integrity and quantifying superficial vein insufficiency severity. Symptomatic patients warrant medical intervention beyond cosmetic treatment. Asymptomatic cosmetic varicose vein patients benefit from office-based treatments (sclerotherapy, endovenous closure) versus surgical approaches. Candidates should accept that varicose veins may recur at different anatomical locations from progressive underlying venous insufficiency despite successful treatment. Contraindications include pregnancy, significant deep venous insufficiency without superficial vein treatment (treating superficial component may unmask serious deep pathology), hypercoagulability disorders, severe immunosuppression, and inability to comply with post-treatment compression requirements.

Treatment Protocol

Varicose vein treatment protocols vary based on vein size, location, and selected modality. Duplex ultrasound imaging guides intervention planning, identifying target veins and assessing venous hemodynamics. Foam sclerotherapy involves injecting foam sclerosing agent (sodium tetradecyl sulfate or polidocanol mixed with sterile air or CO2) into varicose vein under ultrasound guidance. Foam provides excellent contact with vein wall through entire vein length, maximizing therapeutic effect. Endovenous radiofrequency ablation employs ultrasound-guided catheter placement within vein; radiofrequency energy heats vein wall to 60-85°C causing thermal coagulation and vein closure. Endovenous laser ablation similarly uses 1064-nm or 1470-nm wavelength laser delivered through intravascular fiber causing thermal vein wall damage. Percutaneous phlebectomy surgically removes varicose vein segments through small puncture incisions enabling ambulatory office-based removal. Each session typically lasts 30-60 minutes. Compression garments (30-40 mmHg) worn post-treatment for 1-2 weeks optimize outcomes. Multiple sessions may be necessary addressing extensive varicose vein distribution.

Expected Results & Timeline

Varicose vein treatment success rates vary by modality and intervention appropriateness. Foam sclerotherapy achieves 80-90% vein closure rate following single treatment; however, approximately 10-20% require repeat injections. Endovenous thermal ablation demonstrates 95%+ vein closure rates with extremely low reopening rates compared to sclerotherapy. Percutaneous phlebectomy effectively removes targeted varicose vein segments with potential for residual smaller branches requiring future treatment. Results are not immediately visible; treated veins require 2-4 weeks for complete thrombosis and fibrosis. Skin discoloration from hemosiderin deposition gradually resolves over 3-6 months. New varicose veins develop in approximately 20-40% of successfully treated patients within 5-10 years from underlying progressive venous insufficiency; however, original treated sites show excellent durability. Symptom improvement (swelling, pain reduction, skin quality improvement) may appear sooner than complete cosmetic clearance; some patients report symptom relief within weeks of treatment despite persistent vein visibility during resorption phase.

Risks & Side Effects

Varicose vein treatment adverse effects depend on modality and intervention extent. Sclerotherapy commonly causes transient bruising, erythema, and localized induration at injection sites (resolving 2-4 weeks). Thrombophlebitis (inflammation of treated vein with palpable cord) occurs in 5-15% of treatments, causing mild to moderate tenderness and resolving within 2-4 weeks without intervention. Matting (fine telangiectatic vein formation) develops in 20-30% of sclerotherapy treatments, usually resolving spontaneously or responding to laser treatment. Transient pigmentation changes from hemosiderin deposition occur in 20-30% of patients, gradually resolving over 3-6 months. Endovenous thermal ablation carries rare risks including thromboembolism (blood clot traveling to lungs), saphenous nerve injury causing leg paresthesias (rare but potentially permanent), and skin burns from inadvertent thermal injury. Infection remains exceptionally rare with proper sterile technique. Serious complications (pulmonary embolism, deep venous thrombosis) occur in less than 0.5% of endovenous procedures with appropriate technique and patient selection. Post-treatment swelling may persist 2-4 weeks; compression garment use substantially ameliorates symptoms.

Comparison with Alternatives

Varicose vein treatment modalities demonstrate variable efficacy: sclerotherapy achieves 80-90% closure with potential for recurrence and matting; endovenous thermal ablation achieves 95%+ closure with superior durability; percutaneous phlebectomy effectively removes discrete segments but may require additional treatments for extensive distribution; and surgical stripping remains gold standard for large varicose veins but involves longer recovery and higher complication rates. Compression stockings provide symptom relief without treating underlying veins. Most insurance plans cover medically-indicated varicose vein treatment addressing symptoms or complications; cosmetic-only treatment often remains uncovered. Costs range $1,000-3,000 per session depending on vein extent and treatment modality selected.

When to Consult a Specialist

Schedule consultation with vascular surgeons or vascular medicine specialists when symptomatic varicose veins develop requiring medical evaluation. Dermatologists or interventional radiologists address primarily cosmetic varicose veins through office-based treatment. Duplex ultrasound imaging confirms venous insufficiency diagnosis and guides treatment planning. Consultation confirms appropriate patient selection for office-based versus surgical approaches based on vein characteristics and clinical presentation. Symptomatic improvement expectations and potential new vein development over years should be discussed. Post-treatment complications including persistent swelling, unusual discomfort, skin changes, or signs of thromboembolism warrant specialist follow-up.

Frequently Asked Questions

Q: How is varicose vein treatment different from spider vein treatment?
Spider veins are small superficial vessels amenable to sclerotherapy or laser. Varicose veins are larger, deeper veins often requiring ultrasound-guided foam sclerotherapy or endovenous thermal ablation. Varicose veins carry higher symptom and complication risk warranting appropriate medical evaluation before cosmetic treatment.

Q: Do varicose veins need treatment?
Asymptomatic varicose veins are cosmetic concern only; treatment is optional. Symptomatic veins (pain, swelling, skin changes, ulceration) warrant medical consultation assessing treatment appropriateness and addressing underlying venous insufficiency.

Q: Will my varicose veins return?
Treated veins rarely recur; however, new varicose veins develop in 20-40% of successfully treated patients within 5-10 years from progressive venous insufficiency. Original treatment sites show excellent long-term durability.

Q: What is the best varicose vein treatment?
Endovenous thermal ablation demonstrates superior closure rates (95%+) and durability compared to sclerotherapy (80-90%). Treatment selection depends on vein size, location, and individual factors. Specialists determine optimal approach based on individual characteristics.

References